Role of amino acid side chains in region 17-31 of parathyroid hormone (PTH) in binding to the PTH receptor

被引:24
作者
Dean, Thomas
Khatri, Ashok
Potetinova, Zhanna
Willick, Gordon E.
Gardella, Thomas J.
机构
[1] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA 02114 USA
[3] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada
关键词
D O I
10.1074/JBC.M606179200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The principal receptor-binding domain (Ser(17)-Val(31)) of parathyroid hormone (PTH) is predicted to form an amphiphilic alpha-helix and to interact primarily with the N-terminal extracellular domain (N domain) of the PTH receptor (PTHR). We explored these hypotheses by introducing a variety of substitutions in region 17-31 of PTH-(1-31) and assessing, via competition assays, their effects on binding to the wild-type PTHR and to PTHR-delNt, which lacks most of the N domain. Substitutions at Arg(20) reduced affinity for the intact PTHR by 200-fold or more, but altered affinity for PTHR-delNt by 4-fold or less. Similar effects were observed for Glu substitutions at Trp(23), Leu(24), and Leu(28), which together form the hydrophobic face of the predicted amphiphilic alpha-helix. Glu substitutions at Arg(25), Lys(26), and Lys(27) (which forms the hydrophilic face of the helix) caused 4-10-fold reductions in affinity for both receptors. Thus, the side chains of Arg(20), together with those composing the hydrophobic face of the ligand's putative amphiphilic alpha-helix, contribute strongly to PTHR-binding affinity by interacting specifically with the N domain of the receptor. The side chains projecting from the opposite helical face contribute weakly to binding affinity by different mechanisms, possibly involving interactions with the extracellular loop/transmembrane domain region of the receptor. The data help define the roles that side chains in the binding domain of PTH play in the PTH-PTHR interaction process and provide new clues for understanding the overall topology of the bimolecular complex.
引用
收藏
页码:32485 / 32495
页数:11
相关论文
共 39 条
[1]   Structural requirements for conserved arginine of parathyroid hormone [J].
Barbier, JR ;
MacLean, S ;
Whitfield, JF ;
Morley, P ;
Willick, GE .
BIOCHEMISTRY, 2001, 40 (30) :8955-8961
[2]   STABILIZED NMR STRUCTURE OF THE HYPERCALCEMIA OF MALIGNANCY PEPTIDE PTHRP[ALA-26](1-34)AMIDE [J].
BARDEN, JA ;
KEMP, BE .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1994, 1208 (02) :256-262
[3]   A highly effective dominant negative αs construct containing mutations that affect distinct functions inhibits multiple Gs-coupled receptor signaling pathways [J].
Berlot, CH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (23) :21080-21085
[4]   LARGE DIFFERENCES IN THE HELIX PROPENSITIES OF ALANINE AND GLYCINE [J].
CHAKRABARTTY, A ;
SCHELLMAN, JA ;
BALDWIN, RL .
NATURE, 1991, 351 (6327) :586-588
[5]   Solution structure of the osteogenic 1-31 fragment of the human parathyroid hormone [J].
Chen, ZG ;
Xu, P ;
Barbier, JR ;
Willick, G ;
Ni, F .
BIOCHEMISTRY, 2000, 39 (42) :12766-12777
[6]  
COHEN FE, 1991, J BIOL CHEM, V266, P1997
[7]   Mechanisms of ligand binding to the parathyroid hormone (PTH)/PTH-related protein receptor:: Selectivity of a modified PTH(1-15) Radioligand for GαS-coupled receptor conformations [J].
Dean, T ;
Linglart, A ;
Mahon, MJ ;
Bastepe, M ;
Jüppner, H ;
Potts, JT ;
Gardella, TJ .
MOLECULAR ENDOCRINOLOGY, 2006, 20 (04) :931-943
[8]   Insights into the structure and molecular basis of ligand docking to the G protein-coupled secretin receptor using charge-modified amino-terminal agonist probes [J].
Dong, MQ ;
Pinon, DI ;
Miller, LJ .
MOLECULAR ENDOCRINOLOGY, 2005, 19 (07) :1821-1836
[9]  
EPAND RM, 1983, MOL CELL BIOCHEM, V57, P41
[10]   ANALYSIS OF PARATHYROID HORMONES PRINCIPAL RECEPTOR-BINDING REGION BY SITE-DIRECTED MUTAGENESIS AND ANALOG DESIGN [J].
GARDELLA, TJ ;
WILSON, AK ;
KEUTMANN, HT ;
OBERSTEIN, R ;
POTTS, JT ;
KRONENBERG, HM ;
NUSSBAUM, SR .
ENDOCRINOLOGY, 1993, 132 (05) :2024-2030